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Abstract
Alharbi, G. Ghadah. Ph.D. The University of Memphis. June 2018. Spectral/Cepstral
Analysis of Voice Quality in Patients with Parkinson's Disease. Major Professor: Eugene H.
Buder, Ph.D.

The purpose of this dissertation was to determine whether Silverman Voice Treatment
(LSVT) affects cepstral/spectral measures of voice quality in speakers with idiopathic
Parkinson’s Disease (PD). The first study investigated the effect of LSVT on cepstral/spectral
measures of sustained /ɑ/ vowels to determine whether voice quality improves. Few studies
have investigated the effects of LSVT on voice quality using acoustic measures, and none
have used cepstral measures. The first study investigated the effect of LSVT on
cepstral/spectral analyses of sustained /ɑ/ vowels produced by speakers. Sustained vowels
were analyzed for cepstral peak prominence (CPP), CPP Standard Deviation (CPP-SD),
Low/High Spectral Ratio (L/H SR), and Cepstral/Spectral Index of Dysphonia (CSID) using
the Analysis of Dysphonia in Speech and Voice (ADSV) program. The study found both
improved harmonic structure and voice quality as reflected in cepstral/spectral measures.
Voice quality in connected speech is important because it is representative of how a typical
individual communicates. Thus, the second study’s goals were: first, to investigate the effect
of LSVT on cepstral/spectral analysis of connected speech; and second, to compare
cepstral/spectral analyses findings in connected speech with findings observed in sustained
phonation. Another goal was to examine individual differences in response to treatment and
compare them to individual changes observed in sustained phonation. The results
demonstrated that CPP increased significantly following LSVT, indicating improved
harmonic dominance as a result of treatment, and CSID decreased following LSVT,
indicating a reduction of the overall severity in connected speech at the group level. Analysis
v

of individual differences demonstrated that only four participants improved by at least one
half Standard Deviation (SD) following treatment in CPP, CPP-SD, and CSID in both
sustained phonation and connected speech tasks. Three showed a reduction in L/H SR in
sustained phonation and only one showed an increase in L/H SR in connected speech. The
other participants’ improvement varied, but the majority demonstrated voice quality
improvement in sustained phonation. The overall results indicated that CPP and CSID were
strong acoustic measures for demonstrating voice quality improvement following treatment in
both tasks connected speech and sustained phonation.
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Chapter 1: General Introduction
The proposed dissertation contains two research studies in response to LSVT in
Parkinson’s Disease (PD) speakers’ voices using Analysis of Dysphonia in Speech and Voice
(ADSV) for acoustic measurement. The first study investigated the effect of LSVT on
cepstral/spectral analyses of sustained /ɑ/ vowels (Alharbi, Cannito, Buder, & Awan, in
review). The second study’s primary goal was to investigate the effect of LSVT on
cepstral/spectral analyses of connected speech. The secondary goal was first to compare
cepstral/spectral analyses findings in connected speech with findings observed in sustained
phonation. Another secondary goal was to examine individual differences in response to
treatment and compare it to individual changes observed in sustained phonation. These
studies will be the first to examine the effect of LSVT on spectral/cepstral characteristics of
voice in patients with PD.
The importance of this study rests in the fact that PD is ranked as the second most
prevalent neurological disorder after Alzheimer’s disease and its speech symptoms result in
reduced intelligibility of speech (Darley, Aronson, & Brown, 1975; Duffy, 2013; Logemann,
Fisher, Boshes, & Blonsky, 1978). PD speech symptoms are classified as hypokinetic
dysarthria, which typically include monopitch, monoloudness, imprecise consonants, variable
rate, breathy vocal quality, harsh voice quality, short rushes of speech, reduced loudness,
inappropriate silences, and low pitch. Laryngeal endoscopic findings demonstrate hypoadduction of the vocal folds (VF), bowing of the VF, supra-glottic tremor and/or hyperfunction, and tremulous movements of the arytenoid cartilage (Hanson & Chuang, 1999).
Providing acoustic biomarkers for diagnosis of PD and monitoring of treatmentrelated changes needs objective acoustic voice analyses and measurement methods to show
how individuals improve their voices following treatment. Acoustical analysis is also
important for monitoring patients and providing feedback in a clinical setting (Rusz, Cmejla,
Ruzickova, & Ruzicka, 2011). Cepstral/spectral analyses implemented in the ADSV is one
1

such acoustic tool that is well-suited for the PD population because these measures do not
depend upon automatic fo cycle identification. These measures are applicable to both
sustained vowels and connected speech, and are validated in the literature (e.g., Awan et al.
2016).
To date, the most effective treatment for speech disorders in PD is the behavioral
therapy known as Lee Silverman Voice Treatment (LSVT®LOUD). LSVT is an intensive
rehabilitation program that focuses on increased vocal loudness and high phonatory effort
with the result of increasing vocal fold adduction (Ramig, Pawlas, & Countryman, 1995;
Smith, Ramig, Dromey, Perez, & Samandari, 1995). LSVT has been shown to produce longterm voice improvements in speakers with PD, with effects lasting up to two years following
treatment (Ramig, Sapir, Countryman, et al., 2001).
The lack of studies investigating the effect of LSVT on voice quality using acoustic
measures motivated the first study (Chapter 2), which assessed the effect of LSVT on
cepstral/spectral characteristics of sustained /ɑ/ vowels. Findings from the first study
(Chapter 2) demonstrated an improvement in voice quality as reflected by cepstral/spectral
results. Findings from the first study then motivated an additional analysis of data collected at
the time of the first study (Chapter 3) to improve our understanding of how the same
participants responded to LSVT in connected speech in comparison to sustained phonation.
Sustained vowels provide a relatively clear window into phonation produced without the
potentially obscuring influences of supra-laryngeal articulation and prosodic variations
(Dromey, 2003; Gerratt, Kreiman, & Garellek, 2016). The second study addresses the
influence of supra-laryngeal articulation and prosodic variations on voice quality before and
after voice therapy. Together these studies will enhance our understanding of acoustic
changes in response to LSVT for two clinical speech tasks produced by speakers with PD.
It should be noted that the current studies did not assess the general efficacy of LSVT as a
voice treatment for PD, although they did include a treatment component. The efficacy of
2

LSVT has been well established in the literature on speech and voice rehabilitation for
several years based on two randomized blind control trials funded by the National Institutes
of Health (Ramig, Countryman, Thompson, & Horii, 1995; Ramig & Dromey, 1996; Ramig,
Sapir, Fox, & Countryman, 2001) and one privately funded delayed treatment onset
randomized control trial (Halpern et al., 2012). In addition, numerous follow-up studies have
been conducted to examine the response of specific experimental variables to LSVT, such as
aerodynamic measures associated with phonation (Ramig & Dromey, 1996), perceived voice
quality in connected speech (Baumgartner, Sapir, & Ramig, 2001), and vowel formant
centralization (Sapir, Spielman, Ramig, Story, & Fox, 2007). Within this context, the present
studies reported in this dissertation evaluated the responses to LSVT of selected acoustic
spectral/cepstral measures, known to be predictive of the severity of voice quality disorders
other than PD (Watts & Awan, 2011), within a sample of speakers with PD.
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Chapter 2: Spectral /Cepstral Analyses of Phonation in Parkinson's Disease Before and
After Voice Treatment
Introduction
More than 500,000 individuals in the United States have been diagnosed with
Parkinson's Disease (PD), with prevalence of 1% of the population over the age of 60 and 5%
prevalence occurring in individuals older than 85 (Reeve, Simcox, & Turnbull, 2014). Speech
and voice difficulties develop during the course of PD in approximately 90% of patients
(Sapir, Ramig, & Fox, 2013). The speech disorder associated with PD is hypokinetic
dysarthria with characteristics that may include monopitch, monoloudness, imprecise
consonants, variable rate, breathy vocal quality, harsh voice quality, short rushes of speech,
reduced loudness, inappropriate silences, and low pitch, all of which result in reduced
intelligibility of speech (Darley et al., 1975; Duffy, 2013; Logemann et al., 1978). However,
the most distinctive speech characteristics are reduced loudness and monotone speech pattern
(Dromey, 2003; Gentil & Pollak, 1995). Speech problems in PD typically affect voice first
then later spread to articulation and fluency as the disorder progresses (Logemann et al.,
1978) with higher incidence of voice disorders than articulatory disorders (Critchley, 1981).
Laryngeal endoscopic findings demonstrate hypo-adduction of the vocal folds (VF), bowing
of the VF, supraglottic tremor and/or hyper-function, and tremulous movements of the
arytenoid cartilage (Hanson, Gerratt, & Ward, 1984).
A variety of treatments such as pharmacological, surgical, or traditional speech
treatment have not proven to be effective for improving patients’ speech and voice quality
(Halpern et al., 2012). In contrast, Lee Silverman Voice Treatment (LSVT®LOUD), which is
an intensive behavioral voice treatment developed for idiopathic PD (Halpern et al., 2012),
has been shown to produce long-term voice improvements in speakers with PD lasting up to
two years following treatment LSVT (Fox et al., 2006; Ramig, Sapir, Fox, et al., 2001). The
primary effect of LSVT is an increase in vocal intensity (Cannito et al., 2012; Ramig,
4

Countryman, et al., 1995). In addition, LSVT has been shown to significantly increase the
maximum duration of sustained vowel phonation, maximum fundamental frequency range,
habitual fundamental frequency, and fundamental frequency variability in speech (Ramig,
Countryman, et al., 1995). LSVT also demonstrates positive perceptual results post treatment
in patients’ voice quality (Baumgartner et al., 2001) and intelligibility (Cannito et al., 2012).
Following LSVT, VF closure during phonation was observed to significantly improve
(Smith et al., 1995). In addition, following LSVT, electroglottographic open quotient
decreases while both subglottal pressure and the rate of airflow shut off increases (Ramig &
Dromey, 1996). These changes should lead to increased dominance of harmonics in the
acoustic spectrum during voicing (Titze, 1995).
To date only two acoustic single-case studies have examined spectral changes in
sustained phonation produced by patients with PD following LSVT. Dromey et al. (2003)
found a reduction in spectral noise and increased high frequency energy, with a reduction in
spectral slope. Cannito et al. (2006) found that harmonic amplitude differences decreased
post-LSVT, which is an indication of better VF closure during phonation, and also observed
decreased spectral tilt in the regions of the F1, F2 and F3 (Hanson & Chuang, 1999).
Furthermore, to the best of our knowledge, no studies have examined spectral/cepstral
measures of dysphonia pre- to post-voice treatment in PD.
Voice acoustic measures may be classified into spectral/cepstral measures and traditional
time-based acoustic periodicity measures, the validity of which depends on the voice signal
type. Traditional time-based acoustic periodicity measures such as jitter (cycle-to-cycle
variations in frequency), and shimmer (cycle-to-cycle variations amplitude) may only be
useful in the description of Type I signals (nearly periodic signals) but are not valid for
measuring Type 2 (signals which have quick qualitative changes such as subharmonics) or
Type 3 (signals that are aperiodic) (Baken & Orlikoff, 2000; Titze, 1995). Due to the
acoustical variability, dysphonia, and subharmonics seen in hypokinetic dysarthria, traditional
5

time-based acoustic measures may not be appropriate (Dromey, 2003; Metter & Hanson,
1986). Thus, acoustic measures such as perturbation are vulnerable to methodological
problems in application to PD because traditional time-based acoustic measures of phonatory
perturbation depend on accurate identification of cycle boundaries (i.e. Fo determination) and
onsets and offsets of cycles are especially difficult to locate if the voice periodicity is already
unclear or perturbed (Hillenbrand, 1987).
Problems with Fo determination have been illustrated by the low correlations between
acoustic and perceptual measures of sustained vowel phonation (Wolfe, Fitch, & Martin,
1997). In addition, Awan and Roy (2009) concluded that time domain measures like jitter and
shimmer and some harmonics to-noise ratio (HNR) algorithm may similarly lack validity
with increased dysphonia severity because of similar problems with Fo determination. The
questionable validity of Fo tracker-based measures with dysphonic voices notwithstanding, it
has been reported that jitter and mean Fo values were increased while intensity range was
decreased in patients with PD compared with healthy participants (Goberman, Coelho, &
Robb, 2002). Similarly, even with lack of validity, researchers applied the measure of jitter in
participants with PD and reported that jitter was reduced in speakers with PD following
LSVT (De Swart, Willemse, Maassen, & Horstink, 2003).
In contrast to traditional Fo perturbation measures, cepstral analysis (Noll, 1967)
estimates the dominance of harmonics without identifying cycle boundaries. The cepstrum is
a Fourier transformation of the log-power spectrum and may be used to quantify the degree to
which harmonics resulting from the quasi-periodic oscillation of the vocal folds dominate the
spectrum. Spectral/cepstral analysis of dysphonia incorporates both cepstral and spectral
measures suited for dysphonia measurement in sustained vowel phonations and connected
speech (Awan, Roy, Jetté, Meltzner, & Hillman, 2010). The measure of Cepstral Peak
Prominence (CPP) provides an indication of the relative amplitude of the dominant harmonic
in the voice signal. CPP standard deviation (SD) provides an indication of the CPP steadiness
6

over time. The Low/High Spectral Ratio (L/H SR), which provides an indication of the
dominance of spectral energy in the low frequency region (below 4kHz) versus energy in the
high frequency region (above 4kHz), has also been reported to be a valid measure for
assessment of various types of dysphonic voices in sustained vowels and continuous speech,
with particular benefit in the categorization of breathy voices (Watts & Awan, 2011) (see
Table 1 for descriptions of these measures). In addition, a composite index—the Cepstral
Spectral Index of Dysphonia (CSID)—incorporates these measures in specific combinations
suited for both sustained vowels, the CAPE-V sentences, and the Rainbow Passage. The CPP
and the CSID have been useful for discriminating dysphonic voices from control voice
samples, as well as pre- vs post-treatment voice characteristics in a variety of voice types
(Awan, Solomon, Helou, & Stojadinovic, 2013; Gillespie, Dastolfo, Magid, & GartnerSchmidt, 2014; Gillespie, Gartner-Schmidt, Lewandowski, & Awan, 2018; Lowell, Kelley,
Awan, Colton, & Chan, 2012; Roy, Mazin, & Awan, 2014; Vogel et al., 2017; Watts &
Awan, 2011).
Table 1
Measure Names and Descriptions

Measure Names

Descriptions

Cepstral Peak Prominence (CPP)

Mean difference between Cepstral Peak and
regression fitted baseline

CPP Standard Deviation (CPP-SD)

Standard deviation of CPP measures across
sample

L/H Spectral Ratio (L/H SR)

Mean ratio of energy below 4 kHz to energy
above 4 kHz. Normal voice signal tend to
have grater low frequency energy than high
frequency energy (KayPentax, 2011).

Cepstral/Spectral Index of Dysphonia
(CSID)

Result of a formula combining above
measures predictive of perceived dysphonia,
with different weightings for material and
sex (Awan et al., 2013)
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To date, few studies have looked at cepstral measures in patients with PD. Cepstral study
of sustained phonation in untreated PD revealed reduced CPP in comparison to healthy
participants (Kapoor & Sharma, 2011). The acoustic spectral voice characteristics of PD
include abnormally increased spectral slope, which correlates with listeners’ judgments of
dysarthria severity and is indicative of breathiness and incomplete glottal closure (Dromey,
2003; Tjaden, Sussman, Liu, & Wilding, 2010). In treated PD, as previously discussed,
reductions in the harmonic spectral slope and decreased spectral tilt have been observed in
two case studies of persons with PD after LSVT (Cannito et al., 2006; Dromey, Ramig, &
Johnson, 1995).
Since a number of previous studies have used spectral and cepstral measures (such as the
CPP and CSID) to characterize hypofunctional voice samples, these measures may be
valuable metrics for examining treatment related change in PD speakers. The present study
expands upon previous work by incorporating cepstral measures which are suited to voice
quality types seen in PD patients, and the physiologic changes that have been reported
(Ramig & Dromey, 1996; Smith et al., 1995) predict that post treatment there should be
changes in the spectrum, most specifically in harmonic structure. Converging evidence from
various studies, while limited, also suggest that as voice intensity increases following LSVT,
there should be systematic changes in the voice harmonic spectrum in speakers with PD.
Therefore, it was the purpose of this study to perform the effect of LSVT on spectral/cepstral
analyses of sustained vowels produced by speakers with PD. This information will enhance
our understanding of how increased vocal intensity and glottal closure affect the spectral
structure of phonation following LSVT.
The goals of this study were accomplished using cepstral/spectral analyses implemented
in the ADSV software program (KayPENTAX, 2011). This study focuses on the effect of
LSVT on cepstral/spectral measures of sustained vowels in order to provide a relatively clear
window into phonation produced by speakers with PD, without the potentially obscuring
8

influences of supralaryngeal articulation and prosodic variations (Dromey, 2003; Gerratt et
al., 2016). Secondary goals of this study included evaluation of relationships among selected
ADSV measures before and after treatment, given that these analyses have not been applied
to a group of speakers with PD.
Given the voice-related physiological changes that have been previously reported
following LSVT in PD, we hypothesize that following LSVT cepstral/spectral measures
should demonstrate stronger harmonic structure (as reflected by increased CPP) resulting
from treatment effects yielding more adequate glottal closure (Smith et al., 1995) during
phonation. A reduction in CPP-SD also is predicted secondary to increased CPP. This in turn
should lead to decreased overall dysphonia, as measured by CSID. Changes in L/H SR may
be found, but given prior reports on spectral effects (Cannito et al., 2006; Dromey, 2003) and
the default 4 kHz cutoff for the L/H ratio in ADSV (see Table 1 for descriptions of these
measures), the direction of effects on this measure is unknown. Giving Cannito et al., (2006)
and Dromey’s (2003) findings and that the third formant (F3) is an important predictor for
treatment related changes for three different vowels (Cannito et al., 2006), we predict that
lowering the L/H SR cutoff to a region below F3 may best capture L/H SR reduction
resulting from a stronger and louder voice following treatment.
Method
Participant information is listed in Table 2. Ten adults were included in this study
(seven males and three females). Ages ranged between 52 and 81 years (mean = 67.5, SD =
8.37). Each participants’ medical diagnosis was idiopathic PD, and the severity of PD was
assessed by using the Mayo Clinic Rating Scales (Duffy, 2005). All were evaluated by an
experienced ASHA certified speech language pathologist (SLP) to verify the presence of
hypokinetic dysarthria with hypophonia before their enrollment in the project. A consent
form approved by the Institutional Review Board of the University of Memphis was signed
by each participant. Prior to enrollment in the study, laryngeal endoscopic examinations were
9

completed by an otolaryngologist for all participants to rule out any VF pathologies that may
contraindicate enrollment in a high-effort voice treatment. In addition, wave files were reanalyzed visually and perceptually to rule out any hyperfictional voice quality from the study.
The enrolled participants were requested to continue following their regular anti-Parkinson
medication schedules as prescribed by their physician throughout the study period. No
additional speech or voice treatment besides LSVT was provided and no participants had
received LSVT prior to the study.
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Table 2
Clinical Characteristics of Ten Speakers with Idiopathic Parkinson’s Disease*

Participant

Sex

age

Years since
diagnosis

medication

1

M

67

7

A, C

Single word
Intelligibility
Score**
62%

Mayo Clinic Dysarthria Rating Scales

Marked monopitch, monoloudnes, reduced loudness,
audible inspiration, short phrases, increased rate, breathy
voice (continuous), imprecise consonants; moderate
reduced stress; mild alternating loudness and harsh voice
2
F
62
11
B
56%
Severe strained-strangled voice, voice tremor, voice
stoppages, prolonged intervals; marked pitch breaks,
monopitch, voice tremor, monoloudness, reduced
loudness, harsh voice, reduced rate, reduced stress,
imprecise consonants; moderate breathy voice (transient)
and weak pressure consonants
3
M
77
6
B
40%
Severe monopitch, monoloudness, reduced loudness,
breathy voice, increased rate, reduced stress, short rushes
of speech, imprecise consonants, repeated phonemes,
irregular articulatory breakdowns; marked harsh voice
and palilalia
4
F
61
3
B
60%
Marked monopitch, monoloudness, reduced loudness,
voice stoppages, increased rate (segments),
Variable rate, short rushes of speech, prolonged
phonemes, irregular articulatory breakdowns;
Moderate breathy voice (transient), prolonged intervals,
inappropriate silence, imprecise consonants
*:A=L-dopa, B = sinemet, C = requip, D = carbo/levodopa, E = amantadine, F = Mirapex, G = comtan, H = sinemet
**as measured by the Assessment of Intelligibility for Dysarthric Speech
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Table 2 (continued)

Participant

Sex

age

Years since
diagnosis

medication

5

F

81

23

D, E, F

Single word
Intelligibility
Score**
50%

Mayo Clinic Dysarthria Rating Scales

Severe monopitch, monoloudness, harsh voice, strainedstrangled voice; marked reduced pitch
Level, pitch breaks, increased rate, variable rate,
imprecise consonants; moderate weak pressure
consonants, repeated phonemes, distorted vowels
6
M
71
27
B, E
NA
Marked monopitch, monoloudness, reduced loudness,
breathy voice (continuous), short phrases, inappropriate
silences; moderated harsh voice; mild excess loudness
variation, reduced stress, prolonged intervals
7
M
72
15
B, F, G
52%
Severe reduced pitch level and imprecise consonants;
marked monopitch, monoloudness, reduced loudness,
weak pressure consonants ;moderate alternating loudness
and reduced stress; mild loudness decay and hoarse voice
8
M
52
3
F
62%
Marked monopitch and monoloudness; moderate reduced
loudness, breathy voice (continuous), reduced stress; mild
harsh voice, reduced rate, simple vocal tics
9
M
46
2
None
55%
Severe monoloudness; marked monopitch, moderate
breathy voice (continuous), short phrases, reduced stress,
inappropriate silence; mild harsh voice
*:A=L-dopa, B = sinemet, C = requip, D = carbo/levodopa, E = amantadine, F = Mirapex, G = comtan, H = sinemet
**as measured by the Assessment of Intelligibility for Dysarthric Speech
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Table 2 (continued)

Participant

Sex

age

Years since
diagnosis

medication

Single word
Intelligibility
Score**
29%

Mayo Clinic Dysarthria Rating Scales

Severe short phrases; marked monopitch, monoloudness,
reduced loudness, breathy voice (transient), weak pressure
consonants, reduced stress, short rushes of speech;
moderate alternating loudness, variable rate, inappropriate
silences, imprecise consonants, repeated phonemes,
irregular articulatory breakdowns; mild prolonged
phonemes
*:A=L-dopa, B = sinemet, C = requip, D = carbo/levodopa, E = amantadine, F = Mirapex, G = comtan, H = sinemet
**as measured by the Assessment of Intelligibility for Dysarthric Speech
10

M

68

20

B

13

Other than having the same diagnosis and no prior speech or voice treatments, the
sample of speakers with PD recruited for this study was clinically diverse. Variable
characteristics of the sample included the following: one participant who experienced
bilateral deep brain stimulation (speaker 6), one participant had a history of bilateral
pallidotomy (speaker 5), three participants used hearing aids (speakers 4, 5, and 8), one
participant did not take anti-Parkinson medication (speaker 9), five participants were
ambulatory (speakers 1, 2, 3, 7, and 8), two participants used walkers with assistance
(speakers 4 and 5), and one participant was a wheelchair user (speaker 6). Prior to final
analyses, acoustic data from speaker 7 were excluded due to severe vocal hyperfunction.
Cepstral analysis has not been reported to be highly effective in the characterization of
severely hyperfunctional, strained voices; (Awan, Roy, Zhang, & Cohen, 2016). Moreover, it
was also questionable whether this participant was a viable candidate for LSVT. Participant
histories revealed a wide range of years since diagnosis, and participants also presented with
varying degrees of severity of PD and of dysarthria. Single word intelligibility (SWI) was
measured by graduate students who found that SWI varied from 29% to 62% as measured by
the Assessment of Intelligibility of Dysarthric Speech (Yorkston & Beukelman, 1984).
Each participant underwent standard LSVT administered by an ASHA certified SLP
who was also a certified LSVT provider. All speakers enrolled in LSVT participated in a total
of 16 sessions for four days a week for four weeks. Speech recordings were obtained on three
different days within one week before and one week after LSVT. Each speaker was instructed
to produce three repetitions of a sustained vowel /a/ holding out the vowel as steady and as
long as she or he can. There were no cues for the participant to produce loud production
during the pre- and post-treatment assessments. Multiple trials were obtained to examine
potential variability of phonation during the recording sessions and to evaluate potential
practice effects (Kent, Kent, & Rosenbek, 1987). Recordings were collected in a sound booth
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using a head mounted condenser microphone (AKG C420) with a flat frequency response
below 10 kHz, positioned out of the breath stream and 4 cm from the corner of the speaker’s
lips (Titze & Winholtz, 1993). Signals were digitized directly to disc at a sampling rate of
44.1 kHz using Kay Elemetrics CSL 4300B hardware (KayElemetrics). Acoustic analyses
were obtained using the KayPENTAX Analysis of Dysphonia in Speech and Voice (ADSV)
software (KayPENTAX, 2011). Prior to ADSV, to approximate a 25 kHz standard for ADSV
analysis and as traditionally used for CSID (Awan et al., 2010), signals were down-sampled
to 22.05 kHz. Each vowel signal was excerpted from a longer file by trimming the onset of
the vowel in accordance with ADSV protocol, as well as the offset of the vowel, to assure a
50 ms silent period before and after each production. Because extraneous noise could impact
the results, trimming was also performed as needed to remove unwanted sections from an
otherwise satisfactory capture such as coughs, throat clears, et cetera.
To reiterate, acoustic measures obtained via the ADSV program included Cepstral
Peak Prominence (CPP), CPP Standard Deviation (CPP-SD), and Cepstral/Spectral Index of
Dysphonia (CSID). The Low/High Spectral Ratio (L/H SR) measure was analyzed twice
using two different frequency cutoffs. First, the ADSV default cutoff 4 kHz was used for both
males and females to restrict the L/H SR into the region of the F1, F2, and F3. Second, the
cutoff was adjusted to 2 kHz for males and 2.5 kHz for females to provide greater focus on
the F1 and F2 regions of the spectrum (the adjusted values were chosen based on consulting
the time-frequency analysis software (TF32) to confirm that the cutoff was right above F1
and F2 and below the F3).
Both intra- and inter-observer measurement reliability were calculated for 67% of
sound files per participant productions by trained graduate students in a speech-language
pathology program. For reliability assessments, all vowel signals were again segmented from
the longer recordings and re-trimmed to include the silent period, then submitted review to

15

the ADSV for analysis. For intra-analyst reliability, data were not reanalyzed until a 4-month
waiting period had passed. Reliability was high for all selected ADSV measures of sustained
vowels for both inter-analyst (r > 0.90, p < 0.001) and intra-analyst (r > 0.90, p < 0.001)
comparisons. Participants’ sustained vowels exhibited increased intensity (dB) from pre-topost treatment, in keeping with expectations of LSVT (t (8) = -3.44 p < 0.05).
Data were analyzed for each of the four acoustic variables using a three-way repeated
measures ANOVA. Within-participants variables were Treatment Period (Pre-Tx, Post-Tx),
Recordings Days (days 1, 2, and 3 Pre-Tx and days 1, 2, and 3 Post-Tx), and Vowel Trials 1,
2, 3 within each recording day. In this study, the day effect was included in the model to
assess whether the treatment effect exceeded day to day variability before and after treatment.
An overall α-level = 0.05 was Bonferonni adjusted to 0.0125 for testing four acoustic
variables. Inter-relationships among variables were evaluated with Pearson’s r correlations
among the four acoustic variables within participants averaged across trials and days within
each pre-Tx period and post-Tx period (α-level = .01 due to the number of correlations). These
correlations are of interest because the CPP is the primary contributer to the CSID (Awan et
al., 2010). However, the correlation among these measures is not known for treatment effects
for persons with PD, where we anticipate that the L/H SR component of CSID may operate
differently than in normative populations.
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Results
Table 3 provides the means and SDs for each measure obtained from the PD
participants before and after LSVT, averaged across recording days. Results indicated that
four acoustic variables demonstrated statistically significant differences from pre-to-post
LSVT: CPP (F (1, 8) = 13.78, p= 0.006, ɳ2 = .63), CPP-SD (F(1, 8) = 10.32 , p= 0.012, ɳ2 =
0.56), adjusted L/H SR cutoff (F(1, 8) = 11.78 , p= 0.009, ɳ2 = 0.60), and CSID (F(1, 8) =
14.99, p= 0.005, ɳ2 = 0.65). L/H SR using the default 4kHz cutoff (F(1, 8) = 1.79, p= 0.217,
ɳ2 = 0.18) did not differ significantly from pre-to-post treatment. There were no statistically
significant main effects or interactions involving days or trials. Selected measures’ data are
depicted in Figure 1, and sample analyses are presented in Figure 2.
Table 3
Descriptive statistics summary for PD group before and after treatment:
Dependent
Variables

Pre-LSVT

Post-LSVT

Mean (SD)

Mean (SD)

CPP

9.96 (1.72)

12.35 (1.38)

CPP SD

1.60 (.49)

1.25 (.33)

L/H SR 4
kHz

36.47 (5.50)

34.60 (5.60)

Adjusted
L/H SR
CSID

34.43 (6.12)

28.94 (5.05)

35.84 (13.80)

21.87 (10.18)
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Treatment

Treatment

Treatment

Treatment

Figure 1. Box plot showing averaged pre-Tx and post-Tx values for CPP, CPPSD, Adjusted L/H SR, and CSID variables.
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Figure 2: Sustained vowel production of PD participant#5 demonstrating increased harmonic structure and reduced spectral noise pre- to posttreatment (Top panels). Bottom panels demonstrate increased CPP from pre-to post-treatment. Pre-treatment CPP= 7.03, Adjusted L/H SR =
34.26, and CSID=51.304. Post-treatment CPP = 13.00, Adjusted L/H SR = 22.22 which indicated the high frequency energy increased following
treatment, and CSID=30.08
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Inspection of relationships among variables before LSVT demonstrated a strong
negative correlation between CPP and CSID which was statistically significant (r = -0.869,
p = 0.002). A strong positive correlation was observed between CPP-SD and CSID (r =
0.837, p = 0.005). In addition, CPP and CPP-SD demonstrated a strong negative correlation
which was statistically significant (r = -0.708, p = 0.033) (See Table 4). Post LSVT, a
significant negative correlation was observed between CPP and CSID (r = -0.756, p = 0.019).
However, no other variables, including CPP, were significantly correlated after treatment
(See Table 5).
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Table 4
Pearson’s r correlations for spectral/ cepstral acoustic variables pre-TX

Pearson Correlation
CPP Pre

Sig. (2-tailed)
N
Pearson Correlation

CPPSD Pre

Sig. (2-tailed)
N
Pearson Correlation

L/H pre

Sig. (2-tailed)
N
Pearson Correlation

CSID pre

CPP Pre

CPPSD Pre

L/H pre

CSID pre

1

-.708*

-.066

-.869**

9
-.708*

.033
9
1

.865
9
.014

.002
9
.837**

.033
9
-.066

9
.014

.970
9
1

.005
9
-.125

.865
9
-.869**

.970
9
.837**

9
-.125

.748
9
1

.002
.005
.748
Sig. (2-tailed)
9
9
9
N
*. Correlation is significant at the 0.05 level (2-tailed).
**. Correlation is significant at the 0.01 level (2-tailed).

21

9

Table 5
Pearson’s r correlations for spectral/ cepstral acoustic variables Post-TX:

CPP Post CPPSD post L/H post CSID Post

Pearson Correlation
CPP Post

Sig. (2-tailed)
N
Pearson Correlation

CPPSD post

Sig. (2-tailed)
N
Pearson Correlation

L/H post

Sig. (2-tailed)
N
Pearson Correlation

CSID Post

1

-.381

-.301

-.756*

9
-.381

.312
9
1

.431
9
-.071

.019
9
.642

.312
9
-.301

9
-.071

.857
9
1

.062
9
-.168

.431
9
-.756*

.857
9
.642

9
-.168

.665
9
1

.019
.062
.665
Sig. (2-tailed)
9
9
9
N
*. Correlation is significant at the 0.05 level (2-tailed).

22

9

Discussion
The primary purpose of this study was to examine the effect of LSVT on cepstral/spectral
analyses to acoustically characterize PD voice quality. The findings demonstrated that CPP
increased significantly following LSVT, indicating improved harmonic dominance as a result
of treatment. These spectral changes are consistent with, and indirectly support, the findings
of previous studies demonstrating increased glottal closure during phonation (Smith et al.,
1995), increased subglottal pressure, and decreased EGG open quotient post LSVT (Dromey
et al., 1995; Ramig & Dromey, 1996). In part, the present findings may reflect the sensitivity
of CPP to variations in vocal loudness/intensity (Maryn, Roy, De Bodt, Van Cauwenberge, &
Corthals, 2009). Awan et al. (2012) showed that CPP increases as vocal loudness increases in
unimpaired speakers from soft to comfortable to loud phonation. However, in Awan et al.
(2012) the mean difference in dB from quiet to comfortable was 6.25 dB and was associated
with an increase in CPP of only 1.11 dB. In addition, the same study showed that the mean
difference in mean dB from comfortable to loud was 6.37 dB and was associated with an
increase in CPP of only 0.6 dB (the change from quiet to loud was a mean dB change of
12.62 dB and associated with a 1.71 dB increase in CPP). In the current study, the mean
increase in sound level pre vs. post-treatment was 7.68 dB, and therefore the significant
increase in CPP reported here probably was not due to increases in vocal loudness and
intensity alone but most probably representative of improved vibratory characteristics and
vocal quality. Prior to treatment there is decreased glottal closure resulting in atypically
breathy phonation, even for soft voice which contributes to severely diminished harmonic
structure. The increases of glottal closure and subglottal pressure post treatment alter vocal
fold vibration yielding both increased periodicity and increased vocal intensity. Additional
research is needed to explore the relationship between CPP and overall intensity in speakers
with PD before and after treatment. The CPP has been described as the most powerful
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acoustic measure for dysphonia severity to date (Gaskill, Awan, Watts, & Awan, 2017;
Maryn et al., 2009). Its large effect size in the present study underscores its value as a
treatment outcome measure for speakers with PD. Increased CPP is also consistent with
previous case studies that demonstrated improved spectral structure and decreased spectral
tilt from pre-to-post LSVT (Cannito et al., 2006; Dromey et al., 1995).
CPP-SD was also observed to significantly differ pre-to-post treatment (see Figure 1).
The significance of the CPP treatment effect and the significance of the CPP-SD suggest that
the dominance of harmonic structure improved following treatment and its variability within
sustained vowel productions reduced significantly as a result of treatment. CPP-SD is
typically expected to be minimal for sustained vowels and the analysis indicated that the PD
participants in the present study did reduce the variability of CPP after treatment compared to
the pre-treatment levels.
The L/H SR did not significantly change after LSVT using the default cutoff of 4 kHz.
Even though Watts & Awan (2011) reported that the L/H SR differentiated normal versus
hypo-functional groups, this measure did not detect the treatment effect in PD speakers in the
present study. One possibility for this finding is that spectral changes following LSVT only
occurred at frequencies below the 4 kHz cutoff. Cannito et al. (2006) reported that there was
upward frequency redistribution of harmonic energy after LSVT, above the second harmonic,
primarily in the regions of F1, F2 and F3 (all below 4 kHz), which was associated with
decreased spectral tilt. In addition, Dromey et al. (2003) found increased high frequency
energy, with a reduction in spectral slope post LSVT. Another possibility is that the hypofunctional voices investigated by Watts & Awan (2011) exhibited greater degrees of
breathiness than our participants with PD: high frequency turbulence of breathiness would
account for a reduced L/H SR, but if the main effect of LSVT treatment was specific to the
generation of stronger harmonic energy overall then it is possible this effect would not be
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seen in the L/H SR. This change in spectral energy distribution was particularly evident and
statistically significant when the L/H ratio cutoff was reduced to restrict the L/H into the
region of the F1, F2 and F3. The significance of the results after lowering the default cutoff
(4 kHz) demonstrated the energy following treatment is redistributed into the higher
frequency region of the spectrum following treatment consistent with Cannito et al. (2006)
and Hanson & Chuang (1999).
Further studies are needed to replicate these findings with a larger data set and to extend
ADSV analyses to phonation elicited at long term follow up post LSVT. It will also be of
interest to directly compare present analyses with other harmonic spectral analytic techniques
that also do not depend upon automatic Fo cycle identification in both sustained vowels and
connected speech produced by individuals with PD.

25

Chapter 3: Spectral /Cepstral Analyses of Connected Speech in Parkinson's Disease as
Compared with Sustained Phonation Before and After Voice Treatment
Introduction
Voice disorders associated with Parkinson’s Disease (PD) were first described by James
Parkinson in 1817: "His words are now scarcely intelligible," "The power of articulation is
lost," "The speech was very much interrupted," "What words he still could utter were monosyllables, and these came out, after much struggle, in a violent expiration, and with such a
low voice and indistinct articulation, as hardly to be understood but by those who were
constantly with him" (Parkinson, 1817, p. 24). This description demonstrates the laryngeal,
respiratory, and articulatory impairments which have since been considered in a variety of
perceptual, acoustic, and physiological studies of persons with PD (Baker, Ramig, Luschei, &
Smith, 1998; Yorkston, 1996). Researchers have found that the most salient speech and voice
characteristics of PD were related to phonatory impairment, with articulation being the
second most affected speech subsystem (Logemann et al., 1978; Ludlow, Bassich, McNeil,
Rosenbek, & Aronson, 1984).
Respiratory and phonatory deficits in a person with PD affect the production of
speech, leading to problems with phrasing and intensity (Ludlow et al., 1984). Respiratory
deficits may cause a reduction in vital capacity, a reduction in intraoral air pressure during
consonant/vowel productions, and abnormal airflow (Ramig, Fox, & Sapir, 2007).
Alternatively, it has been suggested that abnormal movements of both vocal folds (VFs) and
the supra-laryngeal articulators may lead to atypical variation in airflow resistance, which
may explain apparent abnormalities in respiratory function (Ramig et al., 2007). At the
laryngeal level, hypo-adduction of the VFs, bowing of the VFs, supraglottic tremor and/or
hyper-function, and tremulous movements of the arytenoid cartilage have been demonstrated
endoscopically in individuals with PD (Hanson et al., 1984).
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Studies investigating listener impressions of speech and voice characteristics in PD
include decreased vocal intensity, decreased articulatory precision, mono-pitch, breathy or
harsh voice quality in speech tasks (Lam & Tjaden, 2016), and less spectrally distinct
consonants (Tjaden & Wilding, 2004). These are important factors that affect intelligibility
(Baumgartner et al., 2001; Ferrand, 2001). Speech production studies in speakers with PD
demonstrated deficits in oral closure for stop consonants, reduced range of articulator motion
for diadochokinetic (DDK) tasks, deficits in the amplitude and velocity of lip and mandible
movements, and slowed articulator movement during vowel production (Goberman &
Coelho, 2002) and during speech tasks including oral reading of the first paragraph of the
Rainbow Passage (Flint, Black, Campbell-Taylor, Gailey, & Levinton, 1992). It has been
reported that speakers with PD tend to inappropriately produce acoustic energy during the
stop gap of voiceless consonant (Kent, Weismer, Kent, Vorperian, & Duffy, 1999). In
addition, slowness of articulation was indicated by a shallower second formant (F2) slope
(Kim, Kent, & Weismer, 2011). At the supra-segmental level, more pauses and increases in
fundamental frequency (Fo) with a reduction in its variability, reduced sound pressure levels
(SPL), and rate abnormality have also been reported (Tjaden & Wilding, 2004).
A variety of treatments for PD such as pharmacological, surgical, or traditional speech
interventions have not proven to be effective for improving patients’ speech and voice quality
(Halpern et al., 2012; Shimon Sapir et al., 2007). In contrast, the Lee Silverman Voice
Treatment (LSVT®LOUD), which is an intensive behavioral voice treatment developed for
idiopathic PD (Halpern et al., 2012), has been shown to produce long-term voice
improvements in speakers with PD lasting up to two years following treatment LSVT (Fox et
al., 2006; Ramig, Sapir, Fox, et al., 2001). The primary effect of LSVT is an increase in vocal
intensity (Ramig, Countryman, et al., 1995). In addition, LSVT has been shown to
significantly increase the maximum duration of sustained vowel phonation, maximum
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fundamental frequency range, habitual fundamental frequency, and fundamental frequency
variability in speech (Ramig, Countryman, et al., 1995). LSVT also demonstrates positive
changes in perceived voice quality (Baumgartner et al., 2001), acoustic harmonic structure of
sustained vowels (Alharbi, Cannito, Buder, & Awan, in review) and intelligibility posttreatment in speakers with PD (Cannito et al., 2012).
Following LSVT, VF closure during phonation was observed to significantly improve
(Smith et al., 1995). In addition, following LSVT, the electroglottographic open quotient
decreased while both subglottal pressure and the rate of airflow shut off increased (Ramig &
Dromey, 1996). Such changes lead to an increased dominance of harmonics in the acoustic
spectrum during voicing in sustained phonation tasks (Alharbi et al., in review).
In voice quality assessments, it is important to assess connected speech and sustained
vowels. However, many voice quality assessments are drawn from short vowel segments of
sustained vowel tasks (Watts & Awan, 2015). Several reports have found that measurements
obtained from connected speech in certain populations may better predict voice
classifications such as age and gender, and voice disorders than measurements obtained from
sustained vowels (Ma & Love, 2010; Maryn & Roy, 2012; Roy, Mauszycki, Merrill, Gouse,
& Smith, 2007).
Even though connected speech has been found to better predict voice classification
such as age and gender, and differentiating adductor spasmodic dysphonia from muscle
tension dysphonia (Ma & Love, 2010; Roy et al., 2007), it is important to assess both tasks,
connected speech and sustained vowels, because voicing behaviors differ for both connected
speech and sustained phonation. Sustained vowels provide a relatively clear window into the
balance between noise and periodicity related to glottal function or dysfunction without the
potentially obscuring influences of laryngeal and supra-laryngeal articulation and prosodic
variations (Dromey, 2003; Gerratt et al., 2016; Watts & Awan, 2015). Moreover, according
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to Awan et al. (2010), connected speech provides the clinician with information on how the
patient’s vocal parameters are controlled for communicative purposes and the severity of the
voice disorder, Moreover, connected speech correlates better with perception of dysphonia
than do sustained vowels. In addition, individuals with dysphonia perceive their dysphonia
during connected speech to be more impaired than during vowel production (Watts & Awan,
2015).
The choice of assessment tasks remains controversial because dysphonia may be more
prominent for different disorders during sustained phonation or during connected speech
(Awan et al., 2013). Furthermore, we study connected speech because it tells us about
phonation in the face of the potentially obscuring articulatory and prosodic features that are
absent when using sustained vowels. Thus, both tasks are equally important to consider in
assessment and evaluation of therapeutic outcomes.
Voice acoustic measures may be classified into spectral/cepstral measures and
traditional time-based acoustic periodicity measures. Traditional time-based acoustic
measures of phonatory perturbation depend on accurate identification of cycle boundaries for
Fo determination. Such measures include jitter, shimmer and some algorithms for harmonicto-noise ratios. Onsets and offsets of cycles are especially difficult to locate if the voice
periodicity is already unclear or perturbed as with dysphonia (Hillenbrand, 1987). Thus,
traditional time-based acoustic measures may not be appropriate for the analysis of PD due to
the acoustical variability, dysphonia, and subharmonics seen in hypokinetic dysarthria
(Dromey, 2003; Metter & Hanson, 1986). In addition, the characteristics that differentiate
connected speech from sustained phonation, such as rapid pitch and loudness variations,
noise production during consonant production and the short voicing segments in connected
speech (Awan et al., 2010), increase errors in the time-based measures yielding invalid results
for connected speech, especially with severely dysphonic speakers (Peterson et al., 2013).
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In contrast to period-based measurement approaches, spectral/cepstral measures of
dysphonia have been reported to be sensitive for quantifying the degree to which harmonics
dominate the spectrum and therefore the strength of periodicity in the voice. These measures,
however, do not rely on automated identification of cycle boundaries and are therefore not
participant to the limitations noted for traditional period based techniques. In addition,
cepstral measures have been validated for estimating dysphonia severity for a variety of
phonation tasks (Awan et al., 2016; Awan et al., 2013; Gaskill et al., 2017). Moreover, the
utility of these measures has been supported for differentiating typical and disordered voice
production (Watts & Awan, 2011).
Spectral/cepstral analysis of dysphonia incorporates a number of useful acoustic voice
parameters. Cepstral Peak Prominence (CPP) provides an indication of the relative amplitude
of the dominant harmonic in the voice signal. CPP standard deviation (SD) provides an
indication of the CPP variability over time. The L/H SR provides an indication of the
dominance of spectral energy in the low frequency region (below 4 kHz) versus energy in the
high frequency region (above 4kHz). L/H SR SD provides an indication of the L/H SR
variability over time (KayPENTAX, 2011). In addition, a composite index—the Cepstral
Spectral Index of Dysphonia (CSID)—incorporates these measures in specific combinations
suited for sustained vowels, the CAPE-V sentences, and the Rainbow Passage (Watts &
Awan, 2011) (see Table 6 for descriptions of these measures).
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Table 6
Measure Names and Descriptions
Measure Names

Descriptions

Cepstral Peak Prominence (CPP)

Mean difference between Cepstral Peak and
regression fitted baseline

CPP Standard Deviation (CPP-SD)

Standard deviation of CPP measures across
sample

L/H Spectral Ratio (L/H SR)

Mean ratio of energy below 4 kHz to energy
above 4 kHz. Normal voice signal tends to
have greater low frequency energy than high
frequency energy (KayPENTAX, 2011).

Cepstral/Spectral Index of Dysphonia
(CSID)

Result of a formula combining above
measures predictive of perceived dysphonia,
with different weightings for material and
sex (Awan et al., 2013)

In sustained phonation, a periodic signal is expected to represent a well-defined Fo
and harmonic structure associated with steadiness and consistency in its quality, pitch, and
loudness over time, which is indicated by high amplitude CPP. In contrast, dysphonic voice
is characterized by its decreased CPP amplitude and associated with an increase in its
variability over time. In connected speech, normal speakers tend to have an increased CPP
variability over time due to their vocal mechanism transitioning between voice/voiceless
consonant and the normal variation of pitch and loudness. In contrast, for dysphonic voices
CPP tend to have decreased variability in connected speech over time. In sustained
phonation, normal speakers tend to have a high L/H SR due to the concentration of the voice
energy in the frequency region below 4 kHz while dysphonic voice tends to have a reduced
L/H SR due to their high frequency energy above 4 kHz. In connected speech, normal
speakers tend to have increased L/H SR variability over time due to their vocal mechanism
transitioning between voice/voiceless consonants and the variation of pitch and loudness
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across phrases and utterances. On the other hand, dysphonic voices tend to have a decreased
L/H Ratio variability in their connected speech over time (Awan et al., 2010)
The CSID uses different formulas to estimate the dysphonia severity for connected
speech and sustained phonation. For oral readings of the Rainbow Passage, CSID predicts
dysphonia severity from the second and third sentence because these two sentences are >5
seconds in duration, providing a sufficient sample for estimating the speaking Fo (Awan et
al., 2016). The formula for calculating CSID for the spectral/ cepstral analysis (CPP, L/H SR,
and L/H SR SD), incorporated into a multiple regression equation was reported in Awan et al.
(2009):
CSIDR = 154.59 - (10.39xCPP) - (1:08xSR) - (3.71xσ SR),
Where the CSIDR is the Cepstral Spectral Index of Dysphonia computed from the
Rainbow Passage, CPP is mean Cepstral Peak Prominence, SR is the L/H Spectral Ratio, and
σ SR is the standard deviation of the L/H Spectral Ratio (Awan et al., 2009).
For sustained phonation, the formula for calculating CSID for the spectral/ cepstral
analysis (CPP, CPP-SD, L/H SR, and L/H SR SD), incorporated into a multiple regression
equation reported in Awan et al. (2009):
CSIDV = 84.20 – (4.40 x CPP) + (10.62 x σCPP ) – (1.05 x SR ) + (7.61 x σSR) – (10.68 x G)
Where the CSIDV is the Cepstral Spectral Index of Dysphonia computed from the
Rainbow Passage, CPP is mean Cepstral Peak Prominence, σCPP is the standard deviation of
the CPP, SR is the L/H Spectral Ratio, σ SR is the standard deviation of the L/H Spectral
Ratio, and G is the gender variable (Male = 0; Female = 1).
Several authors have supported the use of spectral/cepstral measures in connected
speech. Hillenbrand and Houde (1996) demonstrated that CPP strongly correlated with
perceptual ratings of breathiness, which were obtained from the second sentence of the
Rainbow Passage (Fairbanks, 1960). In addition, Heman-Ackah, Michael, and Goding (2002)
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demonstrated that cepstral peak measures exhibited the strongest correlations with overall
dysphonia and breathiness ratings in continuous speech (using the second sentence of the
Rainbow Passage) and in sustained vowel samples. Gillespie, Dastolfo, Magid, and GartnerSchmidt (2014) concluded that L/H ratio and its SD may be an important outcome measure to
track responses to surgical and behavioral intervention in patients with various voice
disorders including vocal fold lesions, primary muscle tension dysphonia, vocal fold atrophy
or unilateral vocal fold paralysis. Moreover, Awan, Roy, and Dromey (2009) concluded that
spectral/cepstral-based measures are strong measures for assessing dysphonia severity in
continuous speech (the 2nd and 3rd sentences Rainbow Passage), among the various voice
types and severities seen in muscle tension dysphonia speech samples before and after
treatment (Awan, Roy, and Dromey, 2009).
To date, few studies have looked at spectral/cepstral measures in patients with PD.
Cepstral study of sustained phonation in untreated PD revealed reduced CPP in comparison
to healthy participants (Kapoor & Sharma, 2011). In addition, low CPP and L/H ratio, and
higher CSID were demonstrated in untreated PD in comparison to healthy participants
(Byeon et al., 2016). The acoustic spectral voice characteristics of PD include abnormally
increased spectral slope, which correlates with listeners’ judgments of dysarthria severity and
is indicative of breathiness and incomplete glottal closure (Dromey, 2003; Tjaden et al.,
2010). In treated PD, reductions in the harmonic spectral slope and decreased spectral tilt
have been observed in two case studies of persons with PD after LSVT (Cannito et al., 2006;
Dromey et al., 1995). Furthermore, it was reported that CPP, L/H ratio, and CSID in
sustained phonation improved significantly in sustained vowels following LSVT, and the L/H
SR energy redistributed into the higher frequency region of the spectrum (Alharbi, Cannito,
Buder, Awan, in review). To the best of the authors’ knowledge, only one study has
investigated spectral/cepstral characteristics of PD voice quality in the connected speech of
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untreated PD speakers. The study revealed a reduced CPP in comparison to healthy
participants (Byeon, Jin, & Cho, 2016). Investigating CSID in connected speech will clarify
how well this composite measure is suited for speakers with PD. Thus, specifying the
spectral/cepstral characteristics of a specific population such as PD should build our
understanding of how connected speech may improve in this population following voice
treatment.
The primary goal was to study the effect of LSVT on cepstral/spectral analyses in
connected speech for the purpose of understanding acoustic voice quality in a group of
speakers with PD. Given that the cepstral/spectral measures have not been applied to the
evaluation of the effect of voice treatment on connected speech in speakers with PD, the
goals of this study were accomplished using cepstral/spectral analyses implemented in the
ADSV software program. An additional goal was to compare descriptively the effect of task
for the PD group as a whole, comparing cepstral/spectral analyses findings in connected
speech with findings observed in sustained phonation (Alharbi et al., in review). Finally, due
to the heterogeneous nature of speakers with PD, it was also of interest to examine individual
differences in spectral/cepstral measures obtained from the connected speech and sustained
phonation tasks after LSVT. This will provide a better understanding of how phonation with
the inclusion of articulation and prosodic variations of connected speech may differ from the
previously reported spectral/cepstral findings for sustained phonation within the same
individuals.
Based on the findings from Alharbi et al., (in review), it was hypothesized that following
LSVT, cepstral/spectral measures should demonstrate improved harmonic structure in
connected speech, which will be reflected by an increased CPP. CPP-SD is expected to
increase in connected speech following treatment. L/H SR is expected to increase because
participants are expected to improve their consonant precision which will be reflected by the
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reduction of the high-frequency spectral noise (Gillespie et al., 2014). A reduction in the
overall dysphonia (CSID) is also hypothesized due to the perceived reduction of the overall
dysphonia severity that has been reported for connected speech in PD following LSVT
(Baumgartener et al., 2001).
Method

Participant information is listed in Table 7. Nine adults were included in this study
(six males and three females). Ages ranged between 52 and 81 years (mean = 65, SD =
11.20). Each participant’s medical diagnosis was idiopathic PD, and the severity of
hypokinetic dysarthria was assessed using the Mayo Clinic Rating Scales (Duffy, 2005).
Participants were evaluated by an experienced ASHA certified speech language pathologist
(SLP) to verify the presence of hypokinetic dysarthria with hypophonia before their
enrollment in the project. A consent form approved by the Institutional Review Board of the
University of Memphis was signed by each participant. Prior to enrollment in the study,
laryngeal endoscopic examinations were completed by an otolaryngologist for all participants
to rule out any VF pathologies that may contraindicate enrollment in a high-effort voice
treatment. The enrolled participants agreed to continue following their regular anti-Parkinson
medication schedules as prescribed by their physician throughout the study period. No
additional speech or voice treatment besides LSVT was provided and no participants had
received LSVT prior to the study.
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Table 7
Clinical Characteristics of Ten Speakers with Idiopathic Parkinson’s Disease*

Participant

Sex

age

Years since
diagnosis

medication

1

M

67

7

A, C

Single word
Intelligibility
Score**
62%

Mayo Clinic Dysarthria Rating Scales

Marked monopitch, monoloudnes, reduced loudness,
audible inspiration, short phrases, increased rate, breathy
voice (continuous), imprecise consonants; moderate
reduced stress; mild alternating loudness and harsh voice
2
F
62
11
B
56%
Severe strained-strangled voice, voice tremor, voice
stoppages, prolonged intervals; marked pitch breaks,
monopitch, voice tremor, monoloudness, reduced
loudness, harsh voice, reduced rate, reduced stress,
imprecise consonants; moderate breathy voice (transient)
and weak pressure consonants
3
M
77
6
B
40%
Severe monopitch, monoloudness, reduced loudness,
breathy voice, increased rate, reduced stress, short rushes
of speech, imprecise consonants, repeated phonemes,
irregular articulatory breakdowns; marked harsh voice
and palilalia
4
F
61
3
B
60%
Marked monopitch, monoloudness, reduced loudness,
voice stoppages, increased rate (segments),
Variable rate, short rushes of speech, prolonged
phonemes, irregular articulatory breakdowns;
Moderate breathy voice (transient), prolonged intervals,
inappropriate silence, imprecise consonants
*:A=L-dopa, B = sinemet, C = requip, D = carbo/levodopa, E = amantadine, F = Mirapex, G = comtan, H = sinemet
**as measured by the Assessment of Intelligibility for Dysarthric Speech
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Table 2 (continued)

Participant

Sex

age

Years since
diagnosis

medication

5

F

81

23

D, E, F

Single word
Intelligibility
Score**
50%

Mayo Clinic Dysarthria Rating Scales

Severe monopitch, monoloudness, harsh voice, strainedstrangled voice; marked reduced pitch
Level, pitch breaks, increased rate, variable rate,
imprecise consonants; moderate weak pressure
consonants, repeated phonemes, distorted vowels
6
M
71
27
B, E
NA
Marked monopitch, monoloudness, reduced loudness,
breathy voice (continuous), short phrases, inappropriate
silences; moderated harsh voice; mild excess loudness
variation, reduced stress, prolonged intervals
8
M
52
3
F
62%
Marked monopitch and monoloudness; moderate reduced
loudness, breathy voice (continuous), reduced stress; mild
harsh voice, reduced rate, simple vocal tics
9
M
46
2
None
55%
Severe monoloudness; marked monopitch, moderate
breathy voice (continuous), short phrases, reduced stress,
inappropriate silence; mild harsh voice
10
M
68
20
B
29%
Severe short phrases; marked monopitch, monoloudness,
reduced loudness, breathy voice (transient), weak pressure
consonants, reduced stress, short rushes of speech;
moderate alternating loudness, variable rate, inappropriate
silences, imprecise consonants, repeated phonemes,
irregular articulatory breakdowns; mild prolonged
phonemes
*:A=L-dopa, B = sinemet, C = requip, D = carbo/levodopa, E = amantadine, F = Mirapex, G = comtan, H = sinemet
**as measured by the Assessment of Intelligibility for Dysarthric Speech
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Other than having the same diagnosis and no prior speech or voice treatments, the
sample of speakers with PD recruited for this study was clinically diverse. Variable
characteristics of the sample included the following: one participant experienced bilateral
deep brain stimulation (speaker 6), one participant had a history of bilateral pallidotomy
(speaker 5), three participants used hearing aids (speakers 4, 5, and 8), one participant did not
take anti-Parkinson medication (speaker 9), four participants were ambulatory (speakers 1, 2,
3, and 8), two participants used walkers for assistance (speakers 4 and 5), and one participant
used a wheelchair (speaker 6). Participant histories had a wide range of years since diagnosis.
In addition they had great variability of severity of PD and of dysarthria. Single word
intelligibility varied from 29% to 62% as measured by the Assessment of Intelligibility of
Dysarthric Speech (Yorkston & Beukelman, 1984).
Each participant underwent standard LSVT administered by an ASHA certified SLP
who was also a certified LSVT provider. All speakers enrolled in LSVT participated in a total
of 16 sessions for four days a week for four weeks. Speech recordings were obtained on three
different days within one week before and one week after LSVT. Each speaker was instructed
to produce three repetitions of a sustained vowel /ɑ/ holding out the vowel as steady and as
long as she or he can and to read the first paragraph of the Rainbow Passage (Fairbanks,
1960). There were no cues for the participant to produce loud production during the pre- and
post-treatment assessments. Recordings were collected in a sound booth using a head
mounted condenser microphone (AKG C420) with a flat frequency response below 10 kHz,
positioned out of the breath stream and 4 cm from the corner of the speaker’s lips (Titze &
Winholtz, 1993). Signals were digitized directly to disc at a sampling rate of 44.1 kHz using
Kay Elemetrics CSL 4300B hardware (KayElemetrics). Acoustic analyses were obtained
using the KayPENTAX Analysis of Dysphonia in Speech and Voice (ADSV) software
(KeyElemetrics). Prior to ADSV, to approximate the 25 kHz standard for ADSV analysis and
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the CSID standard (Awan et al., 2010), signals were down-sampled to 22.05 kHz for
sustained phonation and for connected speech. For the sustained vowels, each vowel signal
was excerpted from a longer file by trimming the onset of the vowel, as well as the offset of
the vowel. For connected speech, each connected speech signal was excerpted from the first
paragraph of the Rainbow Passage with only the second and third sentences of the passage
being analyzed in accordance with ADSV protocol. Both sustained phonation and connected
speech file onset were trimmed to assure a 50 ms silent period before and after each
production. Because extraneous noise could impact the results, trimming was also performed
as needed to remove unwanted sections from an otherwise satisfactory capture such as
silence, coughs, throat clears, et cetera.
Changes in connected speech intensity were calculated with reference to recorded
calibration tones of known sound pressure level using the 20-log formula, which was
obtained by measuring the integer voltage (root mean square (RMS)) of the calibration tone
from the recording. Then we measured the RMS quantities from the connected speech sample
and placed the obtained values on a dB SPL scale relative to the calibration tone
(20*Log(RMSvoice/RMSCal) while adding the dB value observed on the SPL meter during the
calibration tone to the given log equation (Buder & Cannito, 2009).
Measures of interest were extracted from the PENTAX Analysis of Dysphonia in
Speech and Voice (ADSV) program which included Cepstral Peak Prominence (CPP), CPP
Standard Deviation (CPP-SD), the Low/High Spectral Ratio (L/H SR) measure with the
default 4 kHz cutoff, and Cepstral/Spectral Index of Dysphonia (CSID). Moreover, to
account for the different L/H SR cutoffs (adjusted L/H SR) that have been used for sustained
phonation, which was based on Cannito et al., (2006) and Dromey (2003) findings, the cutoff
was adjusted to 2 kHz for males and 2.5 kHz for females. This was to provide greater focus
on the F1 and F2 regions of the spectrum on sustained phonation (Alharbi et al., in review).
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In connected speech, the ADSV default cutoff 4 kHz was used for both connected speech and
sustained phonation to be consistent in assessing individual differences. The CSID value for
the Rainbow Passage was computed manually using the regression formula reported in Awan
et al. (2009), which includes CPP, L/H RS, and L/H RS SD. For both connected speech and
sustained phonation, participants were recorded on three consecutive days preceding and
three consecutive days following LSVT with three trials performed for the sustained vowel
/ɑ/ per day.
Both intra- and inter-observer measurement reliability were calculated for 67% of
sound files for sustained vowels and 51% of sound files for connected speech per participant
productions by trained graduate students in a speech-language pathology program. For
reliability assessments, all vowel signals and connected speech were again segmented from
the longer recordings and re-trimmed to include the silent period, then submitted to the
ADSV for analysis. For intra-analyst reliability, data were not reanalyzed until a 4-month
waiting period had passed. Reliability was high for all selected ADSV measures of sustained
vowels and connected speech for both inter-analyst (r > 0.90, p < 0.001) and intra-analyst (r
> 0.90, p < 0.001) comparisons. Overall vocal SPL (dB) was analyzed using paired sample ttests averaged across days within each pre-Tx period and post-Tx period.
The present study included four stages of analysis. First, it was necessary to evaluate
the effect of LSVT in terms of its primary target variable, acoustic voice intensity (dBspl), on
the connected speech production of current sample of speakers with PD. This was
accomplished by comparing their dB levels of their recorded rainbow passages to test the a
priori prediction that dB would increase significantly from pre-to-post treatment based on
extensive prior literature which supports this claim. A paired-samples t-test was conducted at
alpha level = .05 (two-tailed) was computed at alpha level = .05 (one-tailed). Confirmation of
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this prediction was required to motivate further evaluation of the experimental hypothesis
with respect to spectral/cepstral measures.
The second stage of analysis was to examine the experimental hypotheses regarding
the effect of LSVT on selected spectral/cepstral measures of voice in connected speech. A
two-way repeated measures ANOVA was used to examine changes in spectral/cepstral
measures for connected speech from pre-to-post LSVT. Within-participants variables were
Treatment Period (Pre-Tx, Post-Tx) and Recordings Days (days 1, 2, and 3 Pre-Tx and days 1,
2, and 3 Post-Tx). An overall α-level = 0.05 was Bonferonni adjusted to 0.0125 for testing the
significance of effects for each of the four acoustic variables. In addition, a Bonferroni
correction procedure was used to counteract the problem of multiple comparisons (Holm,
1979).
The third stage of analysis was to descriptively compare changes in connected speech
with changes in sustained vowels reported in the first study (Alharbi et al., in review). This
was conducted by simply comparing which spectral/cepstral variables were statistically
significant and also by inspecting the means and SDs for both studies, the sustained
phonation and the connected speech. The fourth stage of analysis was to examine individual
differences in both sustained phonation and connected speech in response to LSVT. A change
criterion of one half standard devistion (SD) of the post treatment distribiution was employed.
The value was based on the criteria for identifying a meaningful change using the Cohen’s d
statistic (Cohen, 1988). This criterion is generaly regarded as a moderate effect size, and
therefore was used to detrmine a meaningful increase/decrease in individual participant’s
vocal function from pre- to post-treatment. The SD was considered based on the post
treatment distribution for each acoustic variable. Each participant’s improvement was
calculated relative to the differences between the pre and post treatment values for both
sustained vowel and connected speech. For each participant the four acoustic variables were
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averaged pre-treatment and post-treatment across days for connected speech and across days
and trials for sustained phonation separately.
Results
In the current study, the first stage of analysis was to examine intensity changes to
provide a validation for the treatment efficacy. Results indicate that before LSVT, the
speakers’ mean intensity across days of connected speech was 78.8 dBspl. Following
treatment, the mean connected speech intensity was 81.7 dBspl. These results indicated a
statistically significant increase in intensity (dBspl) for the connected speech task from pre-topost treatment (t (8) = -2.32 p < 0.049), which is in keeping with expectations of the
treatment program.
The second stage of analysis, was the primary goal for the current study, which was to
examine the effect of LSVT on selected spectral/cepstral measures of voice in connected
speech for participants with PD. Table 8 provides the means and SDs for each measure
obtained from the PD participants’ connected speech before and after LSVT, averaged across
recording days. A statistically significant difference from pre-to-post LSVT was found for
one acoustic variable: CPP (F (1, 8) = 10.51, p = 0.012, ɳ2 = .57). The other acoustic
variables did not differ significantly from pre-to-post treatment CPP-SD (F(1, 8) = 4.67, p =
0.063, ɳ2 = 0.37), L/H SR 4kHz cutoff (F(1, 8) = .64, p = 0.445, ɳ2 = 0.08), , and CSID (F(1,
8) = 9.56, p = 0.015, ɳ2 = 0.55). There were no statistically significant main effects or
interactions for days. Sample analyses are presented in Figure 3. It should be noted that
CSID, while not strictly significant at the family-wise adjusted alpha level, was very close to
this cutoff and exhibited a strong effect size. Thus, the Holm-Bonferroni correction
procedure CSID was applied to counteract the problem of loss of power in multiple
comparisons. After applying the Holm-Bonferroni correction procedure CSID exhibited a

42

statistically significant effect (p = .015, given Holm-Bonferroni criterion of p = .016 <.016)
(Holm, 1987).
Table 8
Descriptive statistics summary for PD group for connected speech before and after treatment

Dependent
Variables

Pre-LSVT

Post-LSVT

Mean (SD)

Mean (SD)

CPP

5.96 (1.23)

6.67 (1.25)

CPP SD

3.34 (.49)

3.63 (.71)

L/H SR 4
kHz

35.30 (4.06)

36.12 (5.24)

L/H SD

10.98 (1.88)

10.74 (1.62)

CSID

13.83 (16.59) 6.47 (15.66)
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Figure 3. Rainbow Passage production of PD partisipent # 5 demonstrating increased
harmonic structure and reduced spectral noise pre- to post-treatment (Top panels). Bottom
panels demonstrate increased CPP from pre- to post-treatment. Pre-treatment CPP = 5.34 and
CSID = 26.41. Post-treatment CPP = 7.46 and CSID = 1.01.
The third stage of analysis was to investigate task-related differences for speakers
with PD as a whole for both connected speech and sustained phonation. Table 9 provides the
means and SDs for each measure obtained from the PD participants’ sustained vowel tasks
before and after LSVT, averaged across recording days and trials (Alharbi et al., in review).
The sustained vowel data is being provided in order to compare post-treatment change across
the two speech elicitation tasks. In connected speech, CPP and CSID were statistically
significant, while in sustained phonation four acoustic variables were statistically significant
including CPP, CPP-SD, Adjusted L/H SR, and CSID.
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Table 9
Descriptive statistics summary for PD group sustained phonation before and after treatment
Dependent
Variables

Pre-LSVT

Post-LSVT

Mean (SD)

Mean (SD)

CPP

9.96 (1.72)

12.35 (1.38)

CPP SD

1.60 (.49)

1.25 (.33)

L/H SR 4
kHz

36.47 (5.50)

34.60 (5.60)

Adjusted
L/H SR

34.43 (6.12)

28.94 (5.05)

L/H SD

2.67 (.53)

2.45 (.46)

CSID

35.84 (13.80)

21.87 (10.18)

Adjusted is 2 kHz cutoff for males and 2.5 kHz cutoff for females

The fourth stage of analysis was to examine individual differences in response to
LSVT across the experimental measures. Table 10 summarizes the results for all participants,
indicating who met and who did not meet the criterion (.5 SD) for the selected ADSV
measures for both connected speech and sustained phonation. Intensity improvement
following LSVT on sustained vowels was demonstrated by seven speakers while on
connected speech intensity improvement following LSVT was demonstrated by six speakers
(See Figure 4). CPP attained the half standard deviation criterion for seven participants in
sustained phonation while for connected speech five participants attained the criterion (see
Figure 5). Four participants showed an improved CPP in both sustained phonation and
connected speech. One participant showed an improved CPP in connected speech and no
improvement of CPP in sustained phonation. All participants with PD demonstrated a
reduction in their CPP variability (CPP-SD), while four speakers demonstrated an increased
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CPP-SD following LSVT in connected speech (See Figure 6). In the measure of L/H SR in
sustained phonation, five speakers showed a reduction in the L/H SR. For connected speech,
three speakers demonstrated an increase in L/H SR following treatment, which suggests an
increase in the low frequency energy following treatment (See figure 7). An overall reduction
of dysphonia severity on sustained phonation was observed in eight speakers, while in
connected speech an overall dysphonia severity reduction was demonstrated in four speakers
(See Figure 8).
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Table 10
Individual differences in response to treatment for ADSV selected measures for both sustained phonation and connected speech
Participant

Task
Measure

Sustained Phonation

Connected speech

dB SPL

CPP

CPP-SD

L/H SR

CSID

dB SPL

CPP

CPP-SD

L/H SR

CSID

> 2.89

> .62

< .11

<.62

< 4.11

> 2.45

> .62

> .38

>2.61

< 4.11

4

*

*

*

*

*

*

*

*

*

5

*

*

*

*

*

*

*

*

*

6

*

*

*

*

*

*

*

1

*

*

*

*

*

*

*

8

*

*

*

*

*

*

9

*

*

*

*

3

*

*

*

*

*

*

*

Post-TX .5 SD

2

*

*

*

*

10
*
*
Note. An asterisk indicates a participant who met the one half SD criterion.
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*

*

Figure 4. Line graph showing averaged pre-Tx and post-Tx values for vocal intensity changes per participant for both sustained phonation and
connected speech.
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Figure 5. Line graph showing averaged pre-Tx and post-Tx values for CPP per participant for both sustained phonation and connected speech.
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Figure 6. Line graph showing averaged pre-Tx and post-Tx values for CPP-SD per participant for both sustained phonation and connected
speech.
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Figure 7. Line graph showing averaged pre-Tx and post-Tx values for L/H SR per participant for both sustained phonation and connected
speech.
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Figure 8. Line graph showing averaged pre-Tx and post-Tx values for CSID per participant for both sustained phonation and connected speech.
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Discussion
The primary purpose of this study was to assess hypotheses regarding the effect of
LSVT on selected spectral/cepstral measures of voice in connected speech. Secondary
spectral/cepstral analyses were used to descriptively compare changes in connected speech
with changes in sustained vowels reported in the sustained phonation study reviewed in
chapter 2. In addition, a second secondary goal was to examine individual differences in
response to LSVT across the experimental measures. The current study will first discuss the
primary goal and then the secondary goals.
Effect of LSVT on spectral/cepstral measures in Connected Speech
The spectral/cepstral analysis demonstrated that out of the four spectral/cepstral
variables chosen, CPP and CSID were the only measures that detect treatment-related
changes in connected speech. These findings indicated that the participants had better
harmonic structure following treatment, which indicated the CPP was sensitive to spectral
changes resulting from LSVT and was the voice quality variable that changed the most in
response to LSVT for connected speech. Even with the inclusion of the laryngeal and
supralaryngeal articulation and prosodic variations in connected speech, the CPP was shown
to be the most sensitive cepstral measure to LSVT in that it was not influenced by speaking
condition, which was in agreement with Watts & Awan (2011).
These spectral changes are consistent with, and indirectly support, the findings of
previous studies demonstrating increased glottal closure following intensive voice therapy
(Smith et al., 1995), increased subglottal pressure, and decreased EGG open quotient post
LSVT (Dromey et al., 1995; Ramig & Dromey, 1996). In part, the present findings may also
reflect the sensitivity of CPP to variations in vocal loudness/intensity (Maryn et al., 2009).
CSID was statistically significant, which indicated that CSID was a predictive measure of
perceived dysphonia. This finding supports the clinical significance of the present results for
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a treatment-related voice change post LSVT (Peterson et al., 2013; Alharbi et al., in review).
The present acoustic finding of decreased dysphonia is also consistent with previous
perceptual findings of improved voice quality after LSVT in connected speech (Baumgartner
et al., 2001). Even with the influence of L/H SR (decrease after LSVT) on sustained
phonation as reviewed in the second chapter, CSID was an applicable measure to detect
treatment effects in this population for both connected speech and sustained phonation due its
large effect size.
CPP-SD in the connected speech condition failed to demonstrate any significant
changes following treatment. The present findings for connected speech were not consistent
with Watts & Awan (2011) who demonstrated that the CPP-SD was an effective measure in
examining treatment outcome on hypo-functional groups. The small sample size or the
number of dependent variables (M = 4) may have affected the ability of the statistics to reveal
a significant difference. In addition, it may be related to the great variability in severity.
L/H SR did not show any significant change in response to treatment in connected
speech. This finding was not consistent with findings reported by Watts & Awan (2011), who
found that L/H SR was able to demonstrate treatment related change in individuals with
dysphonia of various etiologies. In addition, the finding was not consistent with Gillespie et
al. (2014) who demonstrated that, in speech, the L/H ratio and its SD may be an important
outcome measure to track responses to behavioral intervention in single voice disorder, which
included vocal fold lesions, primary muscle tension dysphonia, vocal fold atrophy or
unilateral vocal fold paralysis before and after treatment. The current findings may not be
consistent with Watts & Awan (2011) and Gillespie et al., (2014) because the previous
studies did not use participants with PD. The participants in this study may have had different
degrees of breathiness or roughness than the participants in the previous studies.
Additionally, the lack of significance of the L/H SR on connected speech may be due to the
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use of an arbitrary default cut off frequency of 4 kHz for computation of the intensity ratio.
Previous findings for sustained phonation in speakers with PD in review suggested that
restricting the L/H SR cutoff to a region just above the second formant and below the third
formant was more sensitive in detecting treatment effect in PD population (Alharbi et al., in
review). However, in connected speech, adjusting the L/H SR cutoff was not possible due to
the variability of formants across a variety of vowels in connected speech.
Effect of task before and after LSVT on spectral/cepstral measures
CPP and CSID were effective measures in terms of detecting treatment-related change
in sustained phonation, which was consistent with both Paterson et al., (2013) and Alharbi et
al., (in review). As previously discussed, CPP-SD in sustained phonation was observed to be
a statistically significant measure (Alharbi et al., in review) but not in connected speech. The
lack of significant change of the CPP-SD in connected speech may be related to the degree of
severity prior to treatment. The reason L/H SR in connected speech did not show statistically
significant results may be because lowering the cutoff is more sensitive in detecting treatment
effect in participants with PD but lowering the cutoff was not possible in connected speech.
Individual differences before and after LSVT on spectral/cepstral measures
CPP findings indicated that in the present sample, not all participants achieved the .5
SD criterion but as a group still had better harmonic structure following treatment as reflected
in the CPP findings. The finding that fewer speakers improved on CPP in connected speech
than in sustained vowels is not surprising because Watts & Awan (2011), when evaluating
the diagnostic value of spectral/cepstral measures to differentiate hypo-functional speakers
from healthy speakers, demonstrated a smaller effect of CPP in connected speech when
compared to sustained phonation. In addition, when comparing the correlation of CPP with
the dysphonia severity rating, a stronger correlation was observed in sustained phonation
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compared to connected speech (Awan et al., 2010). The present findings agree with Awan &
Watts (2011) that even within the same speaker, the degree of dysphonia severity and/or
voice quality type may be more evident in sustained vowels than in connected speech.
CPP-SD findings indicated a positive effect of the LSVT in increasing some of the
participants’ speech variability in connected speech. During sustained phonation, CPP-SD
was the only measure which met the criterion for all participants, indicating the harmonic
structure was more consistent and steady following treatment. While in connected speech, it
did show improvement in some participants this may be related to the degree of variability in
severity.
L/H SR findings in some of the participants indicated that in the present sample high
frequency energy increased following treatment. For example, participants who did show an
improved L/H SR after treatment may have had more imprecise consonants before treatment
than participants who did not show improvement as what has been perceptually detected in
participant # 2 who was very mild severity prior to treatment. In prior work on disordered
voices other than PD, an improved voice showed an increase in the L/H SR (Awan et al.,
2010). More studies are needed to understand the direction of change in the L/H SR
following treatment in speakers with PD in relation to healthy controls.
CSID findings indicated that only participants who showed a reduction in overall
severity in connected speech also demonstrated a reduction in the overall severity of
sustained phonation (Participants # 1, 4, 5, 6). Among these participants, participants # 1 and
5 were very breathy prior to treatment in both connected speech and sustained phonation
while following treatment their voices were much stronger with no breathiness detected in all
days and trials for sustained phonation and all days for connected speech. These participants
also improved their CPP, which may explain the reduction of the CSID.
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In summary, cepstral/spectral measures have been shown to be valid measures for
estimating dysphonia severity in both sustained vowels and continuous speech (Awan et al.,
2013; Gaskill et al., 2017) and for differentiating typical and disordered voice production.
The present study extends the use of these measures to speakers with PD both for
characterizing speech and voice aspects prior to treatment and for quantifying treatment
outcomes. The present findings also support the use of LSVT as a treatment approach for
improving voice quality in addition to intensity in PD. The current study supports the use of
the CPP and CSID as outcome measures for documenting phonatory changes in connected
speech following LSVT. In addition, it supports the use of the CPP, CPP-SD, Adjusted L/H
SR, and CSID as outcome measures for documenting phonatory changes in sustained
phonation following LSVT. Investigating individual differences demonstrated that
participants # 1, 4, 5, and 6 did improve on CPP, CPP-SD and CSID in both tasks, with more
participants demonstrating an improvement in sustained phonation than in connected speech.
In general, spectral/cepstral measures were representing the degree of severity in voice
quality in some of the participants. For example, a few participants did not show a vocal
intensity improvement but did show slight spectral/cepstral measures improvement. The
participants that exhibited this pattern were very mild breathy prior to treatment, as with
participant #2. In addition, participants who did show improvements were those who had a
breathy voice quality prior to treatment while following treatment there were no breathiness
detected as seen in participants #s 1 & 5. Present results agree with those obtained by
Gillespie al. (2014) indicating that voice change is not consistently demonstrated by CPP,
CPP-SD, L/H SR, L/H SR SD, and CSID for all disorders. In addition, the present findings
suggest that not all individuals will exhibit within-participants effects or the effects may be
very small, and these may vary with different elicitation tasks.
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Further studies are needed to replicate these findings with a larger data set. In
addition, studies are needed to determine the reason for the inconsistency of the
spectral/cepstral measures findings across speaker. Furthermore, it is important to extend
ADSV analyses to phonation elicited at long-term follow-up post LSVT. It will also be of
interest to directly compare present spectral/cepstral measures with other harmonic spectral
analytic techniques in both sustained vowels and connected speech produced by individuals
with PD. In addition, it will be important to perceptually evaluate voice quality in the present
participants to determine how their cepstral/spectral measures may correlate with perceptual
scaling judgements made by trained clinicians. Furthermore, it is important to compare the
spectral/cepstral measures findings with other acoustics measures such as
electroglottographic (EGG) measures and video-laryngoscopy to document the detected
improvement following LSVT.
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Chapter 4: General Conclusion
The two studies included in this dissertation investigated voice quality in participants
with Parkinson's Disease (PD) in two ways: The first study investigated the effect of LSVT
on selected cepstral/spectral measures of sustained /ɑ/ vowels. The second study served to
assess the effect of LSVT on selected spectral/cepstral measures of voice in connected
speech. A secondary goal was to descriptively compare changes in connected speech with
changes in sustained vowels. In addition, it was of interest to examine individual differences
in response to LSVT across the experimental measures in connected speech and compare
findings with what was observed in sustained phonation (Alharbi et al., in review).
The first study (Chapter 2) demonstrated that Cepstral Peak Prominence (CPP), CPP
standard deviation (SD), and Cepstral Spectral Index of Dysphonia (CSID) improved
significantly following LSVT, with similarly strong effect sizes for both CPP and CSID.
Cepstral/spectral measures have been shown to be valid measures for estimating general
dysphonia severity in both sustained vowels and continuous speech (Awan et al., 2013;
Gaskill et al., 2017) and for differentiating typical and disordered voice productions. The first
of the two studies reported here extends these findings to support the use of CPP, CPP-SD,
and CSID as treatment outcome measures for documenting phonatory changes before and
after LSVT in PD. Low/High Spectral Ratio (L/H SR) did not significantly differ using the
default cutoff 4 kHz in sustained phonation. However, based on prior work by Cannito et al.,
(2006) on spectral measures of voice quality in PD, findings suggested the utility of lowering
the L/H SR cutoff to 2 kHz for males and 2.5 kHz for females.
The findings of the primary goal of the second study support the use of both CPP and
CSID in connected speech. It should be recalled that the CSID is a composite measure based
on a regression formula. CSID was comprised of some of the spectral measures that did not
exhibit statistically significant change (i.e., L/H ratio and L/H ratio SD). CSID nonetheless
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reflected the positive effect of treatment on voice quality, which indicated that the CPP may
have been the largest contributor on the CSID.
Task comparisons indicated that CPP and CSID were the best predictors for voice
quality for both connected speech and sustained phonation, with similarly large effect sizes
for both sustained phonation and connected speech. The lack of significance of the L/H SR
may be related to the fact that L/H SR has a different direction for individuals with PD: voice
improvements in the PD population exhibited an increase in high frequency energy, while in
other dysphonic populations this measure would indicate a breathy voice.
Individual differences revealed that only four participants showed an improvement in
sustained phonation and connected speech on CPP, CPP-SD, and CSID, while the other
participants demonstrated greater improvements in sustained phonation than in connected
speech. Even though not all the participants achieved the .5 SD Post-TX criterion for
improvement, CPP by itself was a strong and robust sensitive acoustic variable of voice
quality for both sustained phonation and connected speech on both tasks and in most of the
participants. In addition, CPP-SD was the only measure that achieved the .5 SD criterion for
all the present participants in sustained phonation. The greater and more universal
improvements on sustained phonation do not mean that sustained phonation is a better task
than connected speech for detecting treatment-related changes. Rather, it may mean that the
degree of severity of a participant’s dysarthria may affect connected speech more than
sustained phonation. Another reason may be the fact that the direction of the L/H SR affected
the outcome in connected speech.
Limitations for both studies are the small sample size, no healthy controls. Also both
studies lack perceptual evaluations of changes from pre to post-therapy, which may be an
important step for better understanding the lack of significance for both tasks in selected
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measures either at the group level or individually. Future studies can address this limitation
by having a larger sample size.
Findings from both studies lead us to several considerations for evaluating speakers
with PD. First, lowering the L/H SR in sustained phonation was more sensitive than the
ADSV default cutoff in detecting treatment effects in a population with PD. Second, a
clinician should perceptually judge participants for their candidacy for both LSVT and ADSV
because LSVT is for truly hypofunctional voice quality and cepstral analysis is not highly
effective in characterizing severely hyperfunctional, strained voices (Awan, Roy, Zhang, &
Cohen, 2016). This consideration was raised by the need to exclude participant 7 who
exhibited a severely reduced pitch level, demonstrating that a diagnosis of hypokinetic
dysarthria with hypophonia may not be sufficient for ruling out candidates who exhibit a
hyperfunctional voice quality. These findings confirm prior general dysphonia studies
(Gillespie et al., 2014; Watts & Awan, 2011) indicating that ADSV is an effective voice
assessment tool. In addition, both studies in connected speech and sustained phonation inform
the researcher that ADSV is sensitive to voice quality type, dysphonia severity, and tasks.
In addition, both studies highlight points that need further investigation. First, the
presence of subharmonics in the voice signal increase the energy and this may interact with
treatment and may make pretreatment look better or worse. Therefore, before confirming that
the cepstrum is describing the treatment effects, researchers may better investigate if
cepstrum is appropriate when measuring the main harmonic rather than the subharmonic. Due
to this, researchers need to investigate why the CPP algorithm breaks down during the
presence of subharmonics in the voice signal, which may affect the cepstral analysis. Even
though the cepstrum, in comparison to many other quality measures such as jitter and
shimmer, does not require cycle-to-cycle periodicity detection from the waveform and does
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not rely on Fo extraction, CPP determination does require Fo when choosing the main
rahmonic.
A second topic for future investigation may be to develop a CSID formula suited for a
person with PD that incorporates the new L/H SR direction. Third, researchers must
perceptually evaluate the degree of severity for speakers with PD to account for variability
that also may help to explain the lack of significance on the spectral/cepstral measures. A
fourth area of future research would compare these measures with electroglottographic
(EGG) measures and video-laryngoscopy to document the detected improvement in the first
and second studies. Fifth, future research should apply spectral/cepstral analysis in different
nationalities with PD because ADSV may also be sensitive to language differences,
especially in connected speech.
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